Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia (Q46979676)
Jump to navigation
Jump to search
scientific article published on 7 March 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia |
scientific article published on 7 March 2006 |
Statements
1 reference
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia (English)
1 reference
Jalal K Ghali
1 reference
Michael J Koren
1 reference
James R Taylor
1 reference
Esther Brooks-Asplund
1 reference
Kaisheng Fan
1 reference
Walker A Long
1 reference
Neila Smith
1 reference
7 March 2006
1 reference
91
1 reference
6
1 reference
2145-2152
1 reference
Identifiers
1 reference
1 reference